Table 2.
Patient’s characteristics
| Group 1 n = 103 (76.3%) |
Group 2 n = 32 (23.7%) |
p value | |
|---|---|---|---|
| Age in years, median (IQR) | 71 (58–84) | 64 (47–81) | 0.0011 |
| Initial treatment | 0.5472 | ||
| Surgery (%) | 97 (94.2) | 31 (96.9) | |
| Radiation (%) | 6 (5.8) | 1 (3.1) | |
| FIGO | |||
| I&II (%) | 80 (77.7) | 23 (71.9) | |
| III&IV (%) | 23 (22.3) | 9 (28.1) | |
| FIGO I&II vs. FIGO III&IV | 0.5012 | ||
| Grading | 0.4922 | ||
| 1 (%) | 37 (36) | 8 (25) | |
| 2 (%) | 56 (54) | 21 (66) | |
| 3 (%) | 10 (10) | 3 (9) | |
| Smoking | n = 72 | n = 19 | 0.4212 |
| Yes (%) | 13 (18) | 5 (26) | |
| No (%) | 59 (82) | 14 (74) | |
| Disease-free survival in months, median (IQR) | 10 (5–36) | 23 (4–65.5) | 0.0043 |
| Disease-specific survival in months, median (IQR) | 21 (8–87) | 29.5 (4–116.5) | 0.0163 |
Group 1: p16ink4a < 25%; Group 2: p16ink4a ≥ 25%
at test, bChi-square test, clog-rank